Medigus Ltd
Change company Symbol lookup
Select an option...
MDGS Medigus Ltd
WLDS Wearable Devices Ltd
UP Wheels Up Experience Inc
BRTX BioRestorative Therapies Inc
FRZA Forza X1 Inc
ILMN Illumina Inc
NR Newpark Resources Inc
CGC Canopy Growth Corp
NAOV Nanovibronix Inc
ETON Eton Pharmaceuticals Inc

Health Care : Health Care Equipment & Supplies |
Based in Israel
Company profile

Medigus is a Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras underr micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD)

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
0.62 (11.44%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Cheesecake Factory stock rally looks full, analysts say

2:54 pm ET January 25, 2023 (MarketWatch)

By Emily Bary

Two analysts downgrade Cheesecake Factory's stock this week

Can investors have their CAKE and eat it, too?

A pair of Wall Street analysts are skeptical, recently downgrading shares of Cheesecake Factory Inc.'s stock (CAKE) in the wake of a 29% run-up in the restaurant name from the start of January through Monday's close.

"While CAKE could continue to benefit from customer brand affinity and earnings upside potential exists if targets are reached, we think potential pressured industry demand, ongoing cost headwinds and limited macro visibility highlight risk to the recent move higher in shares and expectations," UBS analyst Dennis Geiger wrote in a note to clients Wednesday.

The Cheesecake Factory has a number of factors working in its favor, including "uniquely strong brand perceptions, A+ locations, and solid execution," in Geiger's view. But he also worries that the company will be impacted by consumer wallet pressures, especially in the wake of a recent UBS survey.

Respondents "most commonly cited the high costs of CAKE's food and having less free spending money as factors driving decreased visits," he wrote. Additionally, Cheesecake Factory lagged behind its peers during the Great Recession.

Cheesecake Factory shares were near flat on the heels of Geiger's Wednesday downgrade to sell from neutral, but they crumbled 8% on Tuesday after Raymond James analyst Brian Vaccaro moved to market perform from outperform.

"We believe buy-side sentiment is quite negative on the stock, noting that short interest reached 19% of the float exiting 2022," Vaccaro wrote in his note to clients.

He sees the company facing a more neutral risk/reward balance currently, and shared that he was cautious on Cheesecake Factory's earnings outlook.

Shares of the company are up nearly 19% so far this year, compared with a roughly 4% rise for the S&P 500 index over the same span.

-Emily Bary


(END) Dow Jones Newswires

January 25, 2023 14:54 ET (19:54 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.